CLRB - Cellectar Biosciences GAAP EPS of -$1.28 misses by $0.04
- Cellectar Biosciences press release ( NASDAQ: CLRB ): Q3 GAAP EPS of -$1.28 misses by $0.04 .
- As of September 30, 2022, the company had cash and cash equivalents of $17.8 million, compared to $35.7 million as of December 31, 2021.
For further details see:
Cellectar Biosciences GAAP EPS of -$1.28 misses by $0.04